Structural basal ganglia disorders

Gene: SLC30A10

Green List (high evidence)

SLC30A10 (solute carrier family 30 member 10)
EnsemblGeneIds (GRCh38): ENSG00000196660
EnsemblGeneIds (GRCh37): ENSG00000196660
OMIM: 611146, Gene2Phenotype
SLC30A10 is in 10 panels

2 reviews

Sarah Leigh (Genomics England Curator)

Treatable Tag: The condition can involve hypermagnesemia, with gastrointestinal, neurologic, and other sequelae, and chelation therapy has been described as beneficial in some individuals
Created: 14 Mar 2017, 3:36 p.m.
Comment when marking as ready: Associated with phenotype in OMIM, not in G2P. At least 5 variants reported in 5 unrelated cases
Created: 14 Mar 2017, 3:36 p.m.

Manju Kurian (UCL-Institute of Child Health)

Green List (high evidence)

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

History Filter Activity

16 Mar 2017, Gel status: 4

panel promoted to version 1

Sarah Leigh (Genomics England Curator)

promoted 16/03/2017

14 Mar 2017, Gel status: 4

Gene classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

This gene has been classified as Green List (High Evidence).

14 Mar 2017, Gel status: 4

Set publications

Sarah Leigh (Genomics England Curator)

Publications for SLC30A10 were set to 22341972; 22341971

14 Mar 2017, Gel status: 4

Gene classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

This gene has been classified as Green List (High Evidence).

1 Mar 2017, Gel status: 0

Created

Manju Kurian (UCL-Institute of Child Health)

SLC30A10 was created by Manju

1 Mar 2017, Gel status: 0

Added New Source

Manju Kurian (UCL-Institute of Child Health)

SLC30A10 was added to Structural basal ganglia disorderspanel. Sources: Literature